FMR LLC 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:22 am Purchase | 2024-12-31 | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 1,090,585 12.800% | 121,156 (+12.50%) | Filing |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 969,429 14.999% | 34,991 (+3.74%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 934,438 14.999% | 245,584 (+35.65%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 688,854 14.999% | 122,025 (+21.53%) | Filing |